Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGSWW) Shares Outstanding (Weighted Average) (2020 - 2025)

GeneDx Holdings has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $28.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $28.6 million for Q4 2025, up 6.51% from a year ago — trailing twelve months through Dec 2025 was $28.6 million (up 6.51% YoY), and the annual figure for FY2025 was $28.6 million, up 6.51%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $28.6 million at GeneDx Holdings, down from $28.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for WGSWW hit a ceiling of $63.1 million in Q3 2021 and a floor of $549778.0 in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $25.1 million (2023), compared with a mean of $20.8 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 50904527.42% in 2021 and later tumbled 84.57% in 2022.
  • GeneDx Holdings' Shares Outstanding (Weighted Average) stood at $666515.0 in 2021, then skyrocketed by 1435.89% to $10.2 million in 2022, then soared by 137.49% to $24.3 million in 2023, then rose by 10.61% to $26.9 million in 2024, then rose by 6.51% to $28.6 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $28.6 million (Q4 2025), $28.8 million (Q3 2025), and $28.6 million (Q2 2025) per Business Quant data.